Kwong et al [5] interviewed 12 breast cancer patients with a BRCA1/2 mutation who were willing to undergo a contralateral prophylactic mastectomy, mainly to reduce the anxiety about tumor recurrence. The gene discussed is BRCA1; the disease is neoplasm.